Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2010
09/23/2010US20100239552 Combination Therapies for Treating Metabolic Disorders
09/23/2010US20100239538 Compositions comprising vascular and myocyte progenitor cells and methods of their use
09/23/2010US20100239523 Tlr modulators and methods for using the same
09/23/2010US20100239520 Organic compounds
09/23/2010US20100239507 Surface modified aerosol particles, a method and apparatus for production thereof and powders and dispersions containing said particles
09/23/2010US20100236958 Radiopharmaceutical composition
09/23/2010DE102010001064A1 Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung Substituted 2-acetamido-5-aryl-1,2,4-triazolones and their use
09/23/2010DE102009014165A1 Product, useful e.g. to treat and prevent disorders or diseases of lungs, cardiovascular and neuronal system caused by inhalation of tobacco smoke and respiratory diseases e.g. asthma, bronchitis and chronic cough, comprises cobalamin
09/23/2010DE102009013642A1 Substituierte Phenylalaninderivate und deren Verwendung Substituted phenylalanine derivatives and the use thereof
09/23/2010CA2835771A1 Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
09/23/2010CA2793800A1 Peptides that inhibit angiotensin converting enzyme and peptides with antioxidant activity purified from ovotransferrin and methods of producing and using the same
09/23/2010CA2755726A1 A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment
09/23/2010CA2755697A1 Amide derivative
09/23/2010CA2755641A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
09/23/2010CA2755590A1 Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiency
09/23/2010CA2755509A1 Agents and methods for tissue repair and regeneration
09/23/2010CA2754509A1 Novel anti-inflammatory agents
09/22/2010EP2229955A1 Fibroblast growth factor receptor-1 inhibitors and methods of treatment using the same
09/22/2010EP2229942A1 2-Aryl-propionic acids and pharmaceutical compositions containing them
09/22/2010EP2229824A1 Covalent milk protein/isothiocyanate complexes
09/22/2010EP2229451A1 Materials and methods for inhibiting mammalian s-nitrosoglutathione reductase
09/22/2010EP2229405A1 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases
09/22/2010EP2229368A1 Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
09/22/2010EP2229173A1 Oxazolidinones for the treatment and/or prophylaxis of heart failure
09/22/2010EP2229172A1 Triazolo [4,5-d] pyrimidine compounds for treatment of abdominal aortic aneurysms
09/22/2010EP2229167A1 Mineralocorticoid receptor modulators
09/22/2010EP2229165A1 Anti-glycation properties of asicatic acid and madecassic acid
09/22/2010EP2229056A1 Compositions for protection against superficial vasodilator flush syndrome, and methods of use
09/22/2010EP1896477B1 Aspartyl protease inhibitors
09/22/2010EP1890721B1 Compositions and methods for treating cardiac conditions
09/22/2010EP1836163B1 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
09/22/2010EP1809271B9 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators
09/22/2010EP1436313B1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
09/22/2010EP1335938B1 Apolipoprotein construct
09/22/2010CN201585758U Therapeutic massage mat adopting traditional Chinese medicine magnetotherapy
09/22/2010CN201585460U Multifunctional pillow health care cap
09/22/2010CN1970015B Enzymatic extraction method of pawpaw polyphenol
09/22/2010CN1943755B A Chinese traditional medicinal composition for treatment of hypertension and its preparation method
09/22/2010CN1943726B A Chinese traditional medicinal composition for treatment of ischemic apoplexy and its preparation method
09/22/2010CN1813782B Composition of ginkgo leaf extract and dipyridamole, medicine containing same and preparing method thereof
09/22/2010CN1612746B Use of HEPCIDIN as a regulator of iron homeostasis
09/22/2010CN101842390A Antibodies against RAMP3
09/22/2010CN101842119A Diagnostic and therapeutic methods and compositions for cardiovascular disease
09/22/2010CN101842108A Use of g-csf for the treatment of stroke
09/22/2010CN101842096A Film-coated preparation
09/22/2010CN101838329A Anti-angiogenesis fusion protein
09/22/2010CN101838323A Anti-platelet thrombolysin and preparation method thereof
09/22/2010CN101838263A Benzimidazole derivative with cardiovascular activity and preparing method and application thereof
09/22/2010CN101838261A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
09/22/2010CN101838253A Preparation method of ligustilide and butylidene phthalide
09/22/2010CN101838213A Method for preparing laminine and pharmaceutically acceptable salts thereof
09/22/2010CN101837127A Medical use of inhibitors of glutaminyl and glutamate cyclases
09/22/2010CN101837114A Medicinal composition for treating palpitation
09/22/2010CN101837102A Traditional Chinese medicine anther cap for controlling cardiovascular and cerebrovascular diseases, preparing method and quality control method thereof
09/22/2010CN101837101A Traditional Chinese medicine anther cap for controlling cardiovascular and cerebrovascular diseases, preparing method and quality control method thereof
09/22/2010CN101837092A Chinese medicament for curing cardiopathy
09/22/2010CN101837090A Chinese medicinal composition for curing cardiac neurosis
09/22/2010CN101837069A Method for preparing eggplant wine
09/22/2010CN101837060A Chinese medicine for adjusting hypertension, hyperlipidemia and hyperglycemia
09/22/2010CN101837059A Method for preparing apple polyphenol
09/22/2010CN101837056A Foot-bath effervescent tablet for improving blood stasis-type thoracic obstruction caused by qi deficiency
09/22/2010CN101837051A New rhodobryum roseum tablet medicament composition
09/22/2010CN101837038A Novel brain-soothing soft capsule and process preparation method thereof
09/22/2010CN101837034A Method for extracting radix achyranthis bidentatae saponin
09/22/2010CN101837032A Blueberry anthocyanin oral solution
09/22/2010CN101837007A Medicinal composition for curing hemorrhoids and preparation method thereof
09/22/2010CN101836999A Medicinal composition for curing cardiovascular diseases
09/22/2010CN101836997A Glycerol/fructose composite and preparation method thereof
09/22/2010CN101836993A Application of 2,3-dihydrogen-3-hydroxymethyl-6-amino-[1,4]-benzoxazine in preparing medicaments for inducing embryonic stem cells to differentiate towards vascular endothelial cells
09/22/2010CN101836981A Compound valsartan benzenesulfonic acid amlodipine medicament composition and new preparation method thereof
09/22/2010CN101836966A Agomelatine-containing orally disintegrating tablet
09/22/2010CN101836963A Medicinal application preparation for curing hypertension
09/22/2010CN101836810A Blood-pressure-reducing pillow
09/22/2010CN101361719B Bromhexine hydrochloric acid orally disintegrating tablet production method
09/22/2010CN101234089B Alkaline fibroblast growth factor liposome vaccine and preparation method and application thereof
09/22/2010CN101121002B Chinese preparatory medicine for treating high blood pressure diseases
09/21/2010US7799913 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
09/21/2010US7799833 System and method for the pretreatment of the endplates of an intervertebral disc
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/21/2010US7799795 chemokine receptor modulators such as N-(1-(3-(4-cyanophenyl)-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-2-yl)ethyl)-N-(2-(ethylsulfonyl)ethyl)-2-(4-fluoro-3-(trifluoromethyl)phenyl)-acetamide, used for the treatment of asthma, allergic and autoimmune diseases
09/21/2010US7799794 Treatment for cardiovascular disease
09/21/2010US7799787 pyridazine derivatives such as N-(2-Cyclopropylethyl)-6-{4-[2-(trifluoromethyl)phenoxy]piperidin-1-yl}pyridazine-3-carboxamide, useful for the prevention and treatment of dyslipidemia, obesity, diabetes, syndrome X, insulin resistance, fatty liver, cancer, cardiovascular and nervous system disorders
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799771 solid dosage form for contraceptives and hormone replacement therapy; very low moisture content to prevent ester hydrolysis; enhanced bioavailability of 17-beta-estradiol acetate; FDA Orange book listed patent for estradiol acetate
09/21/2010US7799763 Muscle-strengthening drugs and anti-inflammatory drugs
09/21/2010US7799760 Use of pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention
09/21/2010US7799349 Isolating autologous mononuclear cells and transplanting locally into injured tissue
09/21/2010US7799335 Differential delivery of nitric oxide
09/21/2010CA2473892C Novel quinoline derivatives
09/21/2010CA2449521C Pharmaceutical formulation, its use, and method for its manufacture
09/21/2010CA2445068C Azo compounds for type i phototherapy
09/21/2010CA2440559C Novel non-imidazole compounds
09/21/2010CA2438593C Glucopyranosyloxypyrazole derivatives and medicinal use thereof
09/21/2010CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2434178C Substituted amine derivatives and methods of use
09/21/2010CA2429308C Novel lactam-substituted pyrazolopyridine derivatives
09/21/2010CA2420568C Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
09/21/2010CA2417148C Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists